Skip Ribbon Commands
Skip to main content
 


Iron reduction by phlebotomy for the prevention and treatment of type 2 diabetes


IRON

Trial Focus

Trial Focus

Diabetes, Endocrine (Hormones)

Objective

        
The major goal of the study is to investigate effects of iron overload on insulin resistance. Subjects randomized to control group (no treatment) or phlebotomy (blood donation) to reduce iron load.

IRB Protocol #

12-0923

Trial Status

Accepting Participants

Contact

Sarah Douglass PA-C at 720-848-7173 or sara.douglass@ucdenver.edu

Location

University of Colorado HospitalUniversity of Colorado Hospital

Eligibility and Other Participant Information


Inclusion Criteria:
•Males and females aged 35-65
•Type 2 diabetes diagnosis
•HbA1c less than 7.5%
•Treated with diet and/or metformin.
•Duration of diagnosis of diabetes < 5 years
  Exclusion Criteria:
•Hereditary hemochromatosis
•Cancer (except cases currently with no evidence of disease)
•Anemia
•Chronic inflammatory conditions (rheumatologic conditions such as rheumatoid arthritis or giant cell arteritis, or chronic infections such as hepatitis B or C) that could affect ferritin (Iron)
•Hemophilia
•Warfarin therapy
•History of GI bleeding
•Current glucocorticoid therapy